Sofía V. Piguillem, Francisco G. Ortega, Julio Raba, Germán A. Messina, Martín A. Fernández-Baldo
Index: 10.1016/j.microc.2018.03.025
Full Text: HTML
The use of a biological marker as an adjunct for screening for invasive aspergillosis (IA) in high-risk patients is attractive, because it is noninvasive and may detect evidence of IA prior to the appearance of clinical signs and symptoms. Galactomannan (GMN) is a polysaccharide cell-wall component that is released by Aspergillus species. In the present work, an electrochemical microfluidic immunosensor for GMN detection was developed. Moreover, copper nanoparticles covered with polyvinylpyrrolidone (CuNPs-PVP) were synthesized, characterized and used in a microfluidic immunosensor based on the use of anti-GMN antibodies as a trapping agent. The concentration of trapped GMN is then electrochemically quantified by HRP-conjugated anti-GMN-antibody. HRP reacted with its enzymatic substrate in a redox process which resulted in the appearance of a current whose magnitude is directly proportional to the concentration of GMN. The immunosensor was validated by analyzing patient samples, and a good correlation with a commercial ELISA was obtained. This microfluidic immunosensor can be applied to the early diagnosis of IA.
Spatial distribution of uranium isotopes in solid nuclear ma...
2018-03-30 [10.1016/j.microc.2018.03.038] |
Spectroscopic methods for the identification and photostabil...
2018-03-29 [10.1016/j.microc.2018.02.029] |
Characterization of organic materials in the decoration of o...
2018-03-28 [10.1016/j.microc.2018.03.036] |
Research on electronic nose system based on continuous wide ...
2018-03-23 [10.1016/j.microc.2018.03.030] |
Reconstruction of chemical fingerprints from an individual's...
2018-03-21 [10.1016/j.microc.2018.03.027] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved